Our previous study showed that changes in the expression levels of several ABC genes (ABCB1, ABCC1, ABCC2, ABCC5, ABCG1, and ABCG2) during neoadjuvant chemotherapy (NAC) were associated with the response to this therapy in breast cancer patients [2]. The gene discussed is ABCB1; the disease is breast carcinoma.